PetVivo & Commonwealth Partner to Elevate Equine Health – Spryng & Precise PRP for Racehorses
Veterinary professionals, equine investors, and biotech innovators — PetVivo (OTCQX: PETV) and Commonwealth are redefining racehorse care through science-backed joint health solutions. In this New to The Street episode, filmed at the New York Stock Exchange, John Lai (CEO of PetVivo) and Chase Chamberlain (CEO of Commonwealth) announce their strategic partnership focused on improving performance and longevity in athletic horses using Spryng with osteocushion technology and Precise PRP.
Commonwealth, the micro-share racehorse ownership platform behind 2023 Kentucky Derby and 2022 Dubai World Cup winners, highlights the value of these regenerative tools in minimizing downtime and maximizing competitive potential. With proven benefits, minimal adverse events, and applications for both elite and companion animals, this partnership signals a major leap in veterinary innovation.
🌿 Aired on New to The Street Ep. 682 | FOX Business, Bloomberg, and YouTube
🏷️ Tags:
#PetVivo #CommonwealthRacehorses #EquineHealth #SpryngTechnology #PrecisePRP #VeterinaryInnovation #RacehorseCare #OsteoarthritisRelief #PetHealth #RegenerativeVetMedicine #EquineTherapy #JointHealthSolutions #HorseRacing #NewToTheStreet #JohnLai #ChaseChamberlain #BiotechInVeterinaryCare
